An pilot study to assess the efficacy of intravenous iron isomaltoside 1000 (Monofer) in the management of anaemia associated with the palliative management of upper gastrointestinal adenocarcinoma
Phase of Trial: Phase IV
Latest Information Update: 10 Jun 2019
Price : $35 *
At a glance
- Drugs Ferric derisomaltose (Primary)
- Indications Chemotherapy-induced anaemia
- Focus Therapeutic Use
- Acronyms IRON
- 07 Jun 2019 This trial has been completed in UK.
- 31 Aug 2018 Biomarkers information updated
- 27 Oct 2016 Planned End Date changed from 31 Dec 2015 to 1 Aug 2017.